Innovative treatments and transformative therapies in brain health are on the horizon thanks to a £35.4 million award to the NIHR Oxford Health Biomedical Research Centre. The award, announced on…
Analysis published earlier this month in The Lancet Psychiatry shows that a lower dose of the most commonly used second-generation antidepressants achieves the best balance of effectiveness and tolerability in…
